Prometheus Biosciences, Inc.

📍 San Diego, United States🗓 Founded 1995👥 113 employees💰 Last funded Mar 2021
Biotechnology Research🌐 prometheusbiosciences.com
Website LinkedIn
We’re a different kind of biotech company. And we’re here to make a difference. Prometheus Biosciences, Inc. (Nasdaq: RXDX), is a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development and commercialization of novel therapeutic and companion diagnostic products for the treatment of immune-mediated diseases. The Company’s precision medicine platform, Prometheus360™, combines proprietary machine learning-based analytical approaches with one of the world’s largest gastrointestinal bioinformatics databases to identify novel therapeutic targets and develop therapeutic candidates to engage those targets. Prometheus Biosciences was named Best Places to Work by Biospace in 2022 and is headquartered in San Diego, CA.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1995
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Prometheus Biosciences, Inc.?
Prometheus Biosciences, Inc. has 1 investors on record on gritt.io.
When did Prometheus Biosciences, Inc. last raise funding?
The most recent investment in Prometheus Biosciences, Inc. recorded on gritt.io was in March 2021.
When was Prometheus Biosciences, Inc. founded?
Prometheus Biosciences, Inc. was founded in 1995.
What industry is Prometheus Biosciences, Inc. in?
Prometheus Biosciences, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Prometheus Biosciences, Inc. based?
Prometheus Biosciences, Inc. is headquartered in San Diego, United States.